Press Release Covis Pharma Group Announces Executive Leadership Appointment in Canada Zug, Switzerland, 14 July 2022 – Covis Pharma Group (the “Company”), a global specialty pharmaceutical company that markets therapeutic solutions for patients with...
Press Release Covis Pharma Provides Update on FDA Public Hearing for Makena® Zug, Switzerland, June 14, 2022 – Covis Pharma GmbH, an affiliate of Group S.à r.l. (collectively, “Covis”), announced today that the U.S. Food & Drug Administration (FDA) anticipates...
Press Release Covis Pharma Group Announces Two Executive Management Team Appointments – Michelle Lock Joins Covis Pharma as Chief Operating Officer. – Also Announces Executive Leadership Transition with the Appointment of Sandy Loreaux as President, U.S. Business....
Press Release Covis Completes Acquisition of Global Respiratory Portfolio of Two Medicines from AstraZeneca – Enters into on an Exclusive Promotion and Distribution Agreement with Novartis for Distribution Rights to Seebri® Breezhaler® and Ultibro® Breezhaler®...
